Menopause-The Journal of the North American Menopause Society

Papers
(The TQCC of Menopause-The Journal of the North American Menopause Society is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Reflecting on the enduring effects of childhood maltreatment590
Validation of the Menopause Transition Scale (MTS)176
Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women63
Risk factors for delayed intrauterine device removal among menopausal women in rural China39
The effect of probiotic administration on the severity of menopausal symptoms and mental health of postmenopausal women: a triple-blind randomized controlled trial in the West of Iran30
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis29
Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women26
Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages25
A call for health equity when addressing menopausal symptoms24
Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments23
Dietary patterns and prevalence of multimorbidity in women in southern Brazil21
#Menopause: the menopause ontology project21
Health screening of middle-aged women: what factors impact longevity?21
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors20
Association between vitamin D and calcium intakes, breast microcalcifications, breast tissue age-related lobular involution and breast density19
Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers19
Risk factors for future osteoporosis in perimenopausal Japanese women17
The association of vasomotor symptoms during the menopausal transition and cognition in later life16
Perimenopause meets life: observations from the Women Living Better Survey16
The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study15
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors15
Menopause hormone therapy and urinary symptoms: a systematic review15
Examining long-term health impacts of multiparity15
Lessons Learned in Clinical Research Recruitment of Midlife Latinas During COVID-1915
Health care concerns in women at midlife: differences by race, ethnicity, and neighborhood socioeconomic status14
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study14
Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)13
Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis13
Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors13
Pharmacological interactions and menopausal hormone therapy: a review13
Association of parity with body mass index and cardiometabolic risk in high-parous women12
Letters to the editor12
Exercise training and vascular function in postmenopausal individuals: a systematic review and meta-analysis12
Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause11
Psychometric evaluation of the German Day-to-Day Impact of Vaginal Aging questionnaire using data from two intervention studies11
Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden11
Screening for factors at midlife associated with reduced longevity in women11
Impact of vitamin D supplementation on modulating heat-shock proteins in postmenopausal women: a randomized, double-blind, placebo-controlled study10
Menopause: The Journal of The North American Menopause Society Volume 29, 202210
Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging10
Efficacy and safety of lemborexant in midlife women with insomnia disorder10
Nonhormone treatments for vasomotor symptoms10
Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion10
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?9
Menopause for justice-involved women: consequences and care in prison systems9
Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study9
Postmenopausal giant ovarian tumor: a rare case report and literature review9
Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial9
Genitourinary syndrome of menopause—I know it when I see it—or do I?8
Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis8
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update8
Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study7
Should vitamin D supplements be prescribed routinely for midlife women?7
Hysterectomy with or without ovarian conservation: similar associations with vascular health?7
Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women7
2022 Annual Meeting of The North American Menopause Society October 12 – 15, 2022, Atlanta, GA7
Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study7
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)7
Composite dietary antioxidant intake and osteoporosis likelihood in premenopausal and postmenopausal women: a population-based study in the United States7
Prasterone in the treatment of mild to moderate urge incontinence: an observational study7
0.2643461227417